AHSA1 c.409_410delinsGC ;(p.K137A)

Variant ID: 14-77929039-AA-GC

NM_012111.2(AHSA1):c.409_410delinsGC;(p.K137A)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.

Journal Of Experimental & Clinical Cancer Research : Cr
Gu, Chunyan C; Wang, Yajun Y; Zhang, Lulin L; Qiao, Li L; Sun, Shanliang S; Shao, Miaomiao M; Tang, Xiaozhu X; Ding, Pinggang P; Tang, Chao C; Cao, Yuhao Y; Zhou, Yanyan Y; Guo, Mengjie M; Wei, Rongfang R; Li, Nianguang N; Xiao, Yibei Y; Duan, Jinao J; Yang, Ye Y
Publication Date: 2022-01-06

Variant appearance in text: AHSA1: K137A
PubMed Link: 34991674
Variant Present in the following documents:
  • Main text
  • 13046_2021_Article_2220.pdf
View BVdb publication page



AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.

Journal Of Experimental & Clinical Cancer Research : Cr
Gu, Chunyan C; Wang, Yajun Y; Zhang, Lulin L; Qiao, Li L; Sun, Shanliang S; Shao, Miaomiao M; Tang, Xiaozhu X; Ding, Pinggang P; Tang, Chao C; Cao, Yuhao Y; Zhou, Yanyan Y; Guo, Mengjie M; Wei, Rongfang R; Li, Nianguang N; Xiao, Yibei Y; Duan, Jinao J; Yang, Ye Y
Publication Date: 2022-01-06

Variant appearance in text: AHSA1: K137A
PubMed Link: 34991674
Variant Present in the following documents:
  • Main text
  • 13046_2021_Article_2220.pdf
View BVdb publication page